ALECTOR INC
NASDAQ: ALEC (Alector, Inc.)
Kemas kini terakhir: 19 jam lalu2.14
0.00 (0.00%)
| Penutupan Terdahulu | 2.14 |
| Jumlah Dagangan | 4,699,039 |
| Harga / Jualan (P/S) | 19.61 |
| Harga / Buku (P/B) | 19.57 |
| Julat 52 Minggu |
| Margin Keuntungan | -139.74% |
| Margin Operasi (TTM) | -1,216.52% |
| EPS Cair (TTM) | -1.26 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -76.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 43.39% |
| Nisbah Semasa (MRQ) | 3.34 |
| Aliran Tunai Operasi (OCF TTM) | -229.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -92.86 M |
| Pulangan Atas Aset (ROA TTM) | -17.22% |
| Pulangan Atas Ekuiti (ROE TTM) | -90.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Alector, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -3.5 |
| Osilator Teknikal | 0.5 |
| Purata | -2.13 |
|
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.61% |
| % Dimiliki oleh Institusi | 80.74% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Merck & Co., Inc. | 30 Jun 2026 | 3,545,719 |
| Spruce Street Capital Lp | 30 Jun 2026 | 2,101,068 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BERKLEY NEIL LINDSAY | - | 2.51 | -29,251 | -73,420 |
| ROSENTHAL ARNON | - | 2.51 | -72,606 | -182,241 |
| WONG-SARAD GRACE | - | 2.56 | -9,446 | -23,666 |
| Jumlah Keseluruhan Kuantiti Bersih | -111,303 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -279,327 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 2.54 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| WONG-SARAD GRACE | Pegawai | 04 Sep 2026 | Jual automatik (-) | 3,625 | 2.46 | 8,918 |
| WONG-SARAD GRACE | Pegawai | 03 Sep 2026 | Jual (-) | 5,165 | 2.51 | 12,964 |
| BERKLEY NEIL LINDSAY | Pegawai | 03 Sep 2026 | Jual (-) | 29,251 | 2.51 | 73,420 |
| ROSENTHAL ARNON | Pegawai | 03 Sep 2026 | Jual (-) | 72,606 | 2.51 | 182,241 |
| WONG-SARAD GRACE | Pegawai | 02 Sep 2026 | Jual automatik (-) | 656 | 2.72 | 1,784 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |